Allopatric tuberculosis host-pathogen relationships are associated with greater pulmonary impairment

Infection, Genetics and Evolution

Volumn 16, Issue , 2013, Pages 433-440

  Pasipanodya, Jotam G ^a,b   Moonan, Patrick K ^b,c   Vecino, Edgar ^b   Miller, Thaddeus L ^b   Fernandez, Michel ^b,d   Slocum, Philip ^e   Drewyer, Gerry ^d   Weis, Stephen E ^b,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Tarrant County Public Health Department   (United States)

^e TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

Genotypes; Lineage; Pulmonary impairment; Race ethnicity; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ALLOPATRY; ARTICLE; COEVOLUTION; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; PRIORITY JOURNAL; PULMONARY IMPAIRMENT AFTER TUBERCULOSIS; SMOKING; SYMPATRY; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CONTINENTAL POPULATION GROUPS; FEMALE; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; PHYLOGENY; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; SMOKING; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 84876460596     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.02.015     Document Type: Article

References (52)

1. Adams K.N., Takaki K., Connolly L.E., Wiedenhoft H., Winglee K., et al. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 2011, 145:39-53.
2. Baena A., Leung J.Y., Sullivan A.D., et al. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Gene. Immun. 2002, 3(8):482-487.
3. Blaser M.J., Kirschner D. The equilibria that allow bacterial persistence in human hosts. Nature 2007, 449(7164):843-849.
4. Blumberg H.M., Burman W.J., Chaisson R.E., et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med. 2003, 167(4):603-662.
5. Boelaert J.R., Gomes M.S., Gordeuk V.R. Smoking, iron, and tuberculosis. Lancet 2003, 362(9391):1243-1244.
6. Brosch R., Gordon S.V., Marmiesse M., Brodin P., Buchrieser C., et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3684-3689.
7. Caws M., Thwaites G., Dunstan S., et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008 Mar, 4(3):e1000034.
8. Centers for Diseases Control and Prevention (CDC) New CDC program for rapid genotyping of mycobacterium tuberculosis isolates. MMWR Morb. Mortal. Wkly. Rep. 2005, 54(2):47.
9. Click E.S., Winston C.A., Oeltman J.E., Moonan P.K., Cowan K.S., Mac Kenzie W.R. Association between Mycobacterium tuberculosis lineage and time to sputum culture conversion. Am. J. Respir. Crit. Care Med. 2012, 185:A3311.
10. Click E.S., Moonan P.K., Winston C.A., Cowan L.S., Oeltmann J.E. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin. Infect. Dis. 2012, 54(2):211-219.
11. Cocchiarella L., Andersson G.B.J. The Respiratory System. Guides to the Evaluation of Permanent Impairment 2000, AMA Press, Chicago. 5th ed. L. Cocchiarella, G.B.J. Andersson (Eds.).
12. Coscolla M., Gagneux S. Does M. tuberculosis genomic diversity explain disease diversity?. Drug Discov. Today Dis. Mech. 2010, 7(1):e43-e59.
13. Cowley D., Govender D., February B., et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin. Infect. Dis. 2008, 47(10):1252-1259.
14. Crowle A.J., Elkins N. Relative permissiveness of macrophages from black and white people for virulent tubercle bacilli. Infect. Immun. 1990, 58(3):632-638.
15. Davies P.D., Yew W.W., Ganguly D., et al. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans. R. Soc. Trop. Med. Hyg. 2006, 100(4):291-298.
16. Domenech P., Reed M.B., Barry C.E. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect. Immun. 2005, 73:3492-3501.
17. Gagneux S. Host-pathogen coevolution in human tuberculosis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012, 367(1590):850.
18. Ghosh S., Moonan P.K., Cowan L., Grant J., Kammerer S., Navin T.R. Tuberculosis genotyping information management system: enhancing tuberculosis surveillance in the United States. Infect. Genet. Evol. 2012, 12(4):782-788.
19. Goren M.B., Brokl O., Schaefer W.B. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: phthiocerol dimycocerosate and the attenuation indicator lipid. Infect. Immun. 1974, 9:150-158.
20. Gumbo T., Louie A., Lui W., Brown D., Ambrose P.G., Bhavnani S.M., Drusano G.L. Isoniazid bacterial activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics ro predict efficacy in different ethnic populations. Antimcrob. Agents Chemother. 2007, 51(7):2329-2336.
21. Homolka S., Niemann S., Russell D.G., Rohde K.H. Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog. 2010, 6:e1000988.
22. Kato-Maeda M., Bifani P.J., Kreiswirth B.N., Small P.M. The nature and consequence of genetic variability within Mycobacterium tuberculosis. J. Clin. Invest. 2001, 107(5):533-537.
23. Kerstjens H.A., Rijcken B., Schouten J.P., Postma D.S. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax 1997, 52(9):820-827.
24. Krishnan N., Malaga W., Constant P., Caws M., Tran T.H., et al. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS One 2011, 6:e23870.
25. Lamichhane G., Tyagi S., Bishai W.R. Designer arrays for defined mutant analysis to detect genes essential for survival of Mycobacterium tuberculosis in mouse lungs. Infect. Immun. 2005, 73:2533-2540.
26. Lee S.S., Mountain J., Koenig B., et al. The ethics of characterizing difference. guiding principles on using racial categories in human genetics. Genome Biol. 2008, 9(7):404.
27. Lin S.S., Kelsey J.L. Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research. Epidemiol. Rev. 2000, 22(2):187-202.
28. Long E.R., Jablon S. Tuberculosis in the army of the United States in World War II: An Epidemiological Study with an Evaluation of X-ray Screening. Veterans Administration Medical Monograph 1955, Veternas Administration, Washington, DC. 82nd ed.
29. Malik A.N., Godfrey-Faussett P. Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect. Dis. 2005, 5(3):174-183.
30. Miller M.R., Crapo R., Hankinson J., et al. General considerations for lung function testing. Eur. Respir J. 2005, 26(1):153-161.
31. Mitchison D.A., Wallace J.G., Bhatia A.L., Selkon J.B., Subbaiah T.V., et al. A comparison of the virulence in guinea-pigs of South Indian and British tubercle bacilli. Tubercle 1960, 41:1-22.
32. Mountain J.L., Risch N. Assessing genetic contributions to phenotypic differences among 'racial' and 'ethnic' groups. Nat. Genet. 2004, 36(Suppl. 11):S48-S53.
33. Nahid P., Bliven E.E., Kim E.Y., Mac Kenzie W.R., Stout J.E., et al. Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS One 2010, 5(5):e10753. 10.1371/journal.pone.0010753.
34. Parwati I., Van C.R., Van S.D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 2010, 10(2):103-111.
35. Pasipanodya J.G., Miller T.L., Vecino M., et al. Pulmonary impairment after tuberculosis. Chest 2007, 131(6):1817-1824.
36. Pasipanodya J.G., McNabb S.J., Hilsenrath P., et al. Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health 2010, 10:259.
37. Pasipanodya J., Vecino E., Miller T.L., et al. Non-Hispanic Whites have higher risk for pulmonary impairment from pulmonary tuberculosis. BMC Public Health 2012, 12(119).
38. Pasipanodya J.G., Shashikant S., Gumbo T. Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of anti-tuberculosis therapy. Clin. Infect. Dis. 2012, 55(2):169-177.
39. Perez-Velez C.M., Marais B.J. Tuberculosis in children. NEJM 2012, 367(4):348-361.
40. Portevin D., Gagneux S., Comas I., Young D. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 2011, 7:e1001307.
41. Risch N., Burchard E., Ziv E., Tang H. Categorization of humans in biomedical research: genes, race and disease. Genome Biol. 2002, 3(7). comment 2007.
42. Rosenberg N.A., Pritchard J.K., Weber J.L., et al. Genetic structure of human populations. Science 2002, 298(5602):2381-2385.
43. Shabbeer A., Cowan L.S., Ozcaglar C., et al. TB-Lineage: an online tool for classification and analysis of strains of Mycobacterium tuberculosis complex. Infect. Genet. Evol. 2012, 12(4):789-797.
44. Stead W.W. Variation in vulnerability to tuberculosis in America today: random, or legacies of different ancestral epidemics?. Int. J. Tuberc. Lung Dis. 2001, 5(9):807-814.
45. Stead W.W., Senner J.W., Reddick W.T., Lofgren J.P. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N. Engl. J. Med. 1990, 322(7):422-427.
46. Supply P., Allix C., Lesjean S., et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 2006, 44(12):4498-4510.
47. Tarrant County Public Health Department, 2010. Division of Tuberculosis Elimination, Tarrant County Public Health, Client Services.
48. van Crevel R., Parwati I., Sahiratmadja E., et al. Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis. J. Infect. Dis. 2009, 200(11):1671-1674.
49. Vecino M., Pasipanodya J.G., Slocum P., et al. Evidence for chronic lung impairment in patients treated for pulmonary tuberculosis. J. Infect. Public Health 2011, 4(5-6):244-252.
50. Weis S.E., Slocum P.C., Blais F.X., et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N. Engl. J. Med. 1994, 330(17):1179-1184.
51. World Health Organization, 2010. Global Tuberculosis Control: WHO, Report, Geneva, Switzerland.
52. Zhivotovsky L.A., Rosenberg N.A., Feldman M.W. Features of evolution and expansion of modern humans, inferred from genomewide microsatellite markers. Am. J. Hum. Genet. 2003, 72(5):1171-1186.